Click here to create your personal news page. The news that appears on Perrigo will appear there and be constantly updated. You can then modify the page, share it with your friends, or export it and have it appear elsewhere.
You can also create a personal news page and follow the news that interests you by clicking on the tab labelled 'New page'.
ALLEGAN, Mich., Aug. 5 /PRNewswire-FirstCall/ -- Perrigo Company
(Nasdaq: ; TASE) announced today that Joseph C. Papa, Perrigo's
Chairman and CEO will present at the Bank of America Specialty
Pharmaceuticals Conference on Thursday, August 7, at 11:00 a.m. (ET) at the
Southampton Inn in Southampton, New York. The presentation will be webcast
on the following link
Perrigo Company is a leading global...
ALLEGAN, Mich., Aug. 5 /PRNewswire-FirstCall/ -- Perrigo Company
(Nasdaq: ; TASE) today announced that it will release financial results
for its fiscal year 2008 on Monday, August 18, 2008 at approximately 8:00
a.m. (ET). The Company will conduct a conference call at 10:00 a.m. (ET)
hosted by Joseph C. Papa, Perrigo's Chairman and Chief Executive Officer.
The conference call will be available live...
The disaster that is Michigan's economy has not squeezed the value out of every company in the state. Perrigo Co. of Allegan, a pharmaceutical outfit that makes 30 billion pills a year, is fast approaching annual sales of $2 billion and has seen value of its stock grow 140% during the past two years.
Company focused on producing quality, affordable healthcare
ALLEGAN, Mich., July 15 /PRNewswire-FirstCall/ -- Perrigo Company
(Nasdaq: ; TASE), the world's largest manufacturer of over-the-counter
healthcare products sold under the store-brand label, announced today its
intent to invest $10.5 million to expand its facilities at its world
headquarters in Allegan, Michigan. The expansion will add 400...
The drugmaker, which makes generics, pharmaceutical compounds and private label, over-the-counter meds, will invest $10.5 million in its existing headquarters and production facilities and receive a tax credit valued at $8.4 million over 12 years, according to the Western Michigan Business Review. And as part of the deal, Perrigo plans to add 99 jobs over the [...]
ALLEGAN, Mich., July 7 /PRNewswire-FirstCall/ -- Perrigo Company
(Nasdaq: ;TASE) announced today that Joseph C. Papa, Perrigo's Chairman
and CEO will present at the Oppenheimer & Co. Inc. 8th Annual Consumer
Growth Conference on Tuesday, July 8, at 4:05 p.m. (ET) at the Four Seasons
Hotel in Boston. The presentation will be webcast on the following link
Perrigo Company is a leading global healthcare...
We are not the Hatfields and the McCoys. Occasionally, even the innovators can be pleased when the generics win a victory -- at least when the case doesn't involve intellectual property, but rather the preemption defense. On Friday, June 13, Perrigo Pharmaceuticals picked off a nice preemption victory in Gaeta v. Perrigo Pharmaceuticals Co., No. C 05-04115, slip op. (N.D. Cal. June 13, 2008). We're...
Take heart, lab rats. Drugmakers may be eliminating research jobs up and down the East Coast, but
Perrigo
is desparate to fill openings. The Michigan company, which markets OTC and prescription meds, went so far as to post a video on YouTube showing a group of chemists grooving to a mechanized beat (actually, some work in Perrigo IT and some are actors).
The hope is that some real scientists will...
Perrigo Company has filed an abbreviated new drug application for Fluocinonide cream 0.1%, a generic version of Vanos cream 0.1%. The company believes that it is the first to file an abbreviated new drug application (ANDA) with a Paragraph IV certification against Vanos.
Company to Acquire Minority Interest in New Entity
ALLEGAN, Mich., May 21 /PRNewswire-FirstCall/ -- Perrigo Company
(Nasdaq: ; TASE) today announced that it has entered into a
collaborative agreement with Cobrek Pharmaceuticals, a newly formed entity
of Pentech Pharmaceuticals Inc., a privately owned company that specializes
in the research and development of niche generic dosage forms. Pentech will
contribute...
ALLEGAN, Mich., May 20 /PRNewswire-FirstCall/ -- Perrigo Company
(Nasdaq: ; TASE) announced today that Joseph C. Papa, Perrigo's
Chairman and CEO will present at the Citi Investment Research Global Health
Care Conference on Wednesday, May 21, at 10:00 a.m. (ET) at the New York
Hilton. The presentation will be webcast on the following link
.
Perrigo Company is a leading global healthcare supplier...
NEW YORK (MarketWatch) -- Perrigo Co. said Tuesday its third-quarter profit totaled $39.97 million, or 42 cents per share, from $17.06 million, or 18 cents per share, in the same quarter a year before. Sales for the quarter were $503.7 million versus $362.3 million in the year-ago quarter. Analysts had expected earnings of 41 cents per share, according to a FactSet Research poll. Allegan, Mich.-based...
